SEATTLE--(BUSINESS WIRE)--April 10, 2006--Pacific Biometrics, Inc. (OTCBB: PBME, “PBI”) has been awarded a contract with a multinational pharmaceutical company (the “Sponsor”) to provide essential laboratory data for a Phase I osteoporosis program. This contract is related to the clinical development of an innovative new treatment for osteoporosis.
